The steady EPS indicates stability in Gyre Therapeutics' profitability, while the significant increase in sales suggests growing demand for its products or services. This positive financial performance, particularly the sales growth, is likely to be viewed favorably by investors, potentially leading to a short-term positive impact on the stock price.